Agents show promise for treatment of non-small-cell lung cancer

摘要

Encouraging results have been reported with targeted agents in several trials in patients with non-small-cell lung cancer (NSCLC), the findings of which were presented this week at the American Society of Clinical Oncology annual meeting.